Responses
Treatments
Short report
Evaluation of response to 13-valent conjugated pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension study
Compose a Response to This Article
Other responses
No responses have been published for this article.